Friday, March 31, 2017 8:01:02 PM
BUYS DATE
100.0% 03/06/17
96.0% 03/07/17
100.0% 03/08/17
85.5% 03/09/17
100.0% 03/10/17
100.0% 03/15/17
97.4% 03/16/17
100.0% 03/17/17
67.2% 03/20/17
75.8% 03/21/17
89.5% 03/22/17
100.0% 03/23/17
100.0% 03/24/17
98.9% 03/27/17
96.3% 03/28/17
100.0% 03/29/17
100.0% 03/30/17
97.2% 03/31/17
Recent HCMC News
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/23/2024 09:05:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 02:06:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:54:19 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/03/2023 09:30:49 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/11/2023 11:28:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/11/2023 11:25:41 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/11/2023 11:21:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/08/2023 08:00:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/28/2023 08:00:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/24/2023 09:11:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/21/2023 08:30:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/18/2023 09:30:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2023 08:30:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:30:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:30:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/28/2023 08:25:38 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM